Sermorelin acetate is the acetate salt form of sermorelin. The longer name does not identify a second peptide with a separate set of promised benefits. It adds chemical detail to the name of the active drug.

That does not mean two products described with those names are interchangeable. Concentration, ingredients, route, preparation method, and the dispensing pharmacy still matter. Use the actual prescription and label to resolve those questions rather than choosing by the shorter product title.

The considered take

Acetate describes the salt form. It does not tell you the concentration, route, quality, approval status, or appropriate amount to use.

The chemical name answers one narrow question

PubChem, drawing on the NCI Thesaurus, identifies sermorelin acetate as the acetate salt of a synthetic 29-amino-acid peptide related to human growth hormone-releasing hormone. The active peptide is still sermorelin; acetate is not an added peptide such as GHK or ipamorelin.

A clinic may shorten the name in advertising while the pharmacy uses the fuller name on the prescription. Ask the pharmacy to reconcile the names if you are unsure. Our basic explanation covers the hormone pathway, while the blend guide addresses genuinely additional active ingredients.

Sources: PubChem / NCI: sermorelin acetate

Historical product records do not approve a current vial

FDA's historical GEREF documentation uses the name sermorelin acetate. Those records help explain the terminology and the older product's history. They do not establish that a newly compounded preparation is the same approved finished product.

FDA does not approve compounded drugs for safety, effectiveness, and quality before marketing in the way it approves finished drug products. A prescription, chemical identity, and historical approval are different facts. The FDA-status guide explains why an old brand name cannot supply a current compound's approval status.

Sources: FDA: historical GEREF chemistry review · FDA: 2013 GEREF withdrawal determination · FDA: Compounding questions and answers

Compare what the label actually specifies

Check the active ingredient list, concentration, total quantity, dosage form, and route. A single-ingredient injectable product is not the same preparation as an oral combination simply because both contain the word sermorelin. Additional ingredients need their own explanation.

Ask how the prescribed amount relates to the supplied concentration and measuring device. Do not calculate a new syringe marking from the drug name or substitute an online mixing chart. The vial-label guide keeps concentration, amount, and volume separate; the dosage-language guide explains the units without prescribing a regimen.

Sources: FDA: Compounding questions and answers · Mayo Clinic: Sermorelin injection information

The name is not a quality certificate

A research supplier can use an accurate chemical name without offering a medication dispensed for patient care. A purity claim or chemical identifier does not establish that a product is suitable for injection, has appropriate storage instructions, or came through a valid prescribing process.

Identify the licensed prescriber and dispensing pharmacy and obtain patient-specific instructions. Do not buy a research-only powder to recreate a prescription at home. The pharmacy checklist helps distinguish a legitimate care pathway from a storefront selling an ingredient.

Sources: NABP: Buy medication safely · FDA: Risks of compounded drugs

Resolve changes before using a refill

If a refill has different wording, ask whether only the printed name changed or whether the preparation changed too. Send both labels through the provider's secure channel and ask the pharmacist to compare them. A familiar-looking vial is not enough to settle the question.

Confirm the instructions for the new product before using the old routine. Our switching-provider guide covers the same issue when care moves to another service. Written confirmation is particularly useful when several people help organize medicines at home.

Sources: FDA: Managing the benefits and risks of medicines · FDA: Drug interactions, what you should know

Sources behind this article

Provider pages describe their own services. They are not independent proof of health outcomes. Pricing and availability can change.

  1. PubChem / NCI: sermorelin acetateNIH chemical reference · Acetate salt identity; not proof of interchangeability of finished products. Checked September 21, 2026.
  2. FDA: historical GEREF chemistry reviewFDA historical record · Identifies sermorelin acetate and GRF(1-29)NH2; historical product details are not directions for current compounded preparations. Checked September 21, 2026.
  3. FDA: 2013 GEREF withdrawal determinationFederal Register / FDA · Historical GEREF products were not withdrawn for safety or effectiveness reasons; this does not approve current compounds.
  4. FDA: Compounding questions and answersUS regulator · Compounded medicines differ from FDA-approved generic drugs.
  5. Mayo Clinic: Sermorelin injection informationClinical or regulatory reference · Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
  6. NABP: Buy medication safelyPharmacy regulator association · Tools for checking online pharmacies and recognizing unsafe sellers.
  7. FDA: Risks of compounded drugsUS regulator · Explains lack of FDA approval and the risks of poor-quality compounded preparations.
  8. FDA: Managing the benefits and risks of medicinesUS regulator · General questions for evaluating benefit, follow-up and new medicines.
  9. FDA: Drug interactions, what you should knowUS regulator · General medicine, food and supplement interaction principles, not an exhaustive sermorelin interaction list.